FDA panel considers first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts